Phase 3 Data: Denifanstat, a First-in-Class, Once-Daily Oral FASN Inhibitor, Hits All Primary Endpoints in Acne Trial

June 4, 2025

U.S. FDA Clears AVAVA’s Focal Point Technology-based Acne Scar Treatment

April 23, 2025

Topline Results: Dermata’s Freshwater Sponge-based Acne Treatment Hits All Primary Endpoints in Phase 3 Trial

March 28, 2025

Can Topical Nigella Sativa With Vinegar Clear Acne?

March 21, 2025

Cabtreo 6-month Acne Data: So Far, So Great

March 14, 2025

Developing Story: L’Oréal SA Issues Recall of Effaclar Duo in the U.S.; New Formulation Coming Soon

March 11, 2025

Dermata Phase 3 Acne Trial Update: Last Patient Completes Last Visit in Trial of Freshwater Sponge-based Treatment

March 5, 2025

UK MHRA Gives Nod to Winlevi for Acne

February 10, 2025

What Factors Are Associated With Relapse After Isotretinoin Treatment for Acne?

January 15, 2025

And the 2024 American Acne and Rosacea Society’s Grant Award Recipients Are…

December 16, 2024

Derm-Biome Adds Dr. Jerry Tan to Its Scientific Advisory Board

November 25, 2024

Fall Clinical News: Clascoterone Cream 1% (Winlevi) Reduces Sebum Levels, Demonstrates Stability When Used With Other Acne Meds

October 26, 2024